These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8734010)

  • 1. Mifepristone: a potential contraceptive.
    Heikinheimo O; Archer DF
    Clin Obstet Gynecol; 1996 Jun; 39(2):461-8. PubMed ID: 8734010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-implantation activity of antiestrogens and mifepristone.
    Dao B; Vanage G; Marshall A; Bardin CW; Koide SS
    Contraception; 1996 Oct; 54(4):253-8. PubMed ID: 8922879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of mifepristone on inhibition of ovulation and induction of luteolysis.
    Spitz IM; Croxatto HB; Lähteenmäki P; Heikinheimo O; Bardin CW
    Hum Reprod; 1994 Jun; 9 Suppl 1():69-76. PubMed ID: 7962472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RU 486: an overview of mifepristone and its potential applications.
    Contracept Rep; 1993 May; 4(2):7-9. PubMed ID: 12286473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiprogestins: mechanism of action and contraceptive potential.
    Spitz IM; Croxatto HB; Robbins A
    Annu Rev Pharmacol Toxicol; 1996; 36():47-81. PubMed ID: 8725382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review.
    Avrech OM; Golan A; Weinraub Z; Bukovsky I; Caspi E
    Fertil Steril; 1991 Sep; 56(3):385-93. PubMed ID: 1894013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergency contraception: a review.
    Haspels AA
    Contraception; 1994 Aug; 50(2):101-8. PubMed ID: 7956209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST; Thong KJ; Baird DT
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-ovulatory contraception.
    Glasier A; Baird DT
    Baillieres Clin Obstet Gynaecol; 1990 Jun; 4(2):283-91. PubMed ID: 2225600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.
    Webb AM; Russell J; Elstein M
    BMJ; 1992 Oct; 305(6859):927-31. PubMed ID: 1458074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term low-dose mifepristone on reproductive function in women.
    Croxatto HB; Kovács L; Massai R; Resch BA; Fuentealba B; Salvatierra AM; Croxatto HD; Zalányi S; Viski S; Krenács L
    Hum Reprod; 1998 Apr; 13(4):793-8. PubMed ID: 9619526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.
    Katkam RR; Gopalkrishnan K; Chwalisz K; Schillinger E; Puri CP
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):779-87. PubMed ID: 7573244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action of RU 486.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Svalander P
    Ann Med; 1993 Feb; 25(1):61-4. PubMed ID: 8435191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ovulation by low-dose mifepristone (RU 486).
    Ledger WL; Sweeting VM; Hillier H; Baird DT
    Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraception after unprotected sex.
    Blaney CL
    Netw Res Triangle Park N C; 1994 Dec; 15(2):4-8. PubMed ID: 12319047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Cameron ST; Critchley HO; Buckley CH; Kelly RW; Baird DT
    Fertil Steril; 1997 Jun; 67(6):1046-53. PubMed ID: 9176442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of anti-progesterones as a medical IUD.
    Nieman LK; Loriaux DL
    Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK
    Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.